ExactechGPS: Guided Personalized Surgery Takes Main Stage Among Exactech’s Orthopaedic Innovations at AAOS 2014 Annual Meet...
March 11 2014 - 9:32AM
Business Wire
Newly Designed Educational Exhibit Provides
Live Demos, Hands on Experience and “Ask the Expert” Exchange
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone
and joint restoration products for hip, knee, shoulder, spine and
biologic materials, announced today its line up of products to be
unveiled at the company’s newly designed educational exhibit, booth
#2261, at the American Academy of Orthopedic Surgeons (AAOS) 2014
Annual Meeting March 11 – 15 in New Orleans, LA.
Exactech Knee
Exactech celebrates 20 years of Exactech Knee, a system that has
demonstrated performance over time with its proven design,
proprietary materials and excellent long-term clinical
results.1
The company commemorates this milestone with full market
introduction of ExactechGPS® Guided Personalized
Surgery, the first advanced surgical technology to provide a
real-time patient-specific solution in total knee arthroplasty.
With a touch screen in the sterile field, ExactechGPS puts
real-time visual guidance and alignment data at the surgeon’s
fingertips. Customized for surgeon preferences, ExactechGPS is a
powerful addition to the surgical team in addressing their goals of
efficacy, efficiency and economics.
The cornerstone of Exactech’s newly designed exhibit is a
surgical skills demonstration area that will allow surgeons to gain
hands-on experience with ExactechGPS and the Optetrak Logic® knee
system.
Exactech Shoulder
Nine years of clinical use and 32 peer-reviewed studies
demonstrate that Exactech had it “Right from the Start.” Now is the
perfect time to learn more about the industry’s fastest growing
shoulder system, Exactech’s Equinoxe® Platform
Shoulder System. The Equinoxe System delivers innovative
solutions to clinical challenges. Throughout the AAOS exhibit time,
design team surgeons and key clinicians will be on hand to share
their experiences and provide product and instrument
demonstrations.
Be among the first to see the latest addition to the Equinoxe
product family -- the new Resurfacing Humeral Head, which
offers modularity, anatomic sizing and low profile instrumentation
for cuff and anatomic preserving approaches in reverse shoulder
surgeries.
Exactech Hip
The Exactech Hip portfolio expands its scope of solutions for
primary hip reconstruction with introduction of LPI Prime.
This femoral stem leverages the proven features of a conventional
stem but is designed to preserve more bone.2 The LPI Prime system
includes specialized instrumentation contained within one tray,
designed for efficiency in any surgical approach.
Exactech Power Equipment
Exactech introduces an updated version of its AcuDriver®
Automated Osteotome System, an air-driven impact handpiece with
precision osteotomes in various sizes for use in revision
surgeries. Live demonstrations available at the Exactech booth’s
surgical skills laboratory.
Exactech Spacer
Exactech’s Interspace® bone cement spacer continues to
be the most widely-studied antibiotic spacer technology in the
world with a 96.1 percent eradication rate.3
Exactech Spine
Exactech Spine is among the fastest growing spine organizations,
developing innovative spinal and orthobiologics solutions to
restore spine health. New at AAOS is the AcapellaTM
One Cervical Spacer System. Offered in a variety of heights,
footprints, and lordotic angles to accommodate varying anatomical
conditions, Acapella One features single-step implantation with an
integrated locking mechanism. Additionally, with the introduction
of the Gibralt® Occipital Plate to the Gibralt
Spinal System, Exactech provides spinal fusion solutions for
the full spine from the occiput, or the back portion of the skull,
to the sacrum, the bone at the base of the spine.
Exactech Biologics
Exactech recognizes the growing importance of biologic solutions
for orthopaedics. Come by the Exactech booth to learn about:
- Optecure® bone matrix and
the flexibility of combining with saline, blood, autogenous bone
marrow and autologous bone graft.
- Accelerate®
Concentrating System: Designed for the safe and rapid
preparation of autologous platelet rich plasma (PRP) from a small
sample of blood at the patient’s point of care.
There’s an App for That
For the latest on activities at Exactech’s newly designed
educational exhibit, Booth #2261 at the AAOS 2014 Annual Meeting,
including a schedule of demonstrations and a schedule of faculty
available for “Ask the Expert” exchanges, surgeons can download an
event app from Exactech’s web page http://www.exac.com/academy.
About Exactech
Based in Gainesville, Fla., Exactech develops and markets
orthopaedic implant devices, related surgical instruments and
biologic materials and services to hospitals and physicians. The
company manufactures many of its orthopaedic devices at its
Gainesville facility. Exactech’s orthopaedic products are used in
the restoration of bones and joints that have deteriorated as a
result of injury or diseases such as arthritis. Exactech markets
its products in the United States, in addition to more than 30
markets in Europe, Latin America, Asia and the Pacific. Additional
information about Exactech, Inc. can be found at
http://www.exac.com. Copies of Exactech’s press releases, SEC
filings, current price quotes and other valuable information for
investors may be found at http://www.exac.com and
http://www.hawkassociates.com.
An investment profile on Exactech may be found at
http://www.hawkassociates.com/profile/exac.cfm. To receive future
releases in e-mail alerts, sign up at
http://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, which represent
the company’s expectations or beliefs concerning future events of
the company’s financial performance. These forward-looking
statements are further qualified by important factors that could
cause actual results to differ materially from those in the
forward-looking statements. These factors include the effect of
competitive pricing, the company’s dependence on the ability of
third party manufacturers to produce components on a basis which is
cost-effective to the company, market acceptance of the company’s
products and the effects of government regulation. Results actually
achieved may differ materially from expected results included in
these statements.
References
1 Data on file at Exactech, Inc. Exactech Knee Literature
Review.
2 Data on file at Exactech (TR-2013-036 and TR-2013-037).
3 InterSpace®-Bibliographies and references on file at Exactech,
Inc. Eradication rate at last follow-up. Interspace® is produced by
Tecres S.p.A., Italy and distributed in North America by
Exactech.
Exactech, Inc.Investor contactsJody Phillips, 352-377-1140Chief
Financial OfficerorHawk AssociatesJulie Marshall or Frank Hawkins,
305-451-1888E-mail: exactech@hawkassociates.comorMedia
contactPriscilla Bennett, 352-377-1140Director Marketing
Communication & Public Relations
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Apr 2024 to May 2024
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From May 2023 to May 2024